Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alexion Pharmaceuticals (ALXN)
NASDAQ:ALXN
RESEARCH TOOLSreports
Holding ALXN?
Track your performance easily
William Blair analyst Raju Prasad maintained a Hold rating on Alexion Pharmaceuticals (ALXN – Research Report) today. The company’s shares closed last Tuesday at $182.50, close to its 52-week high of $187.45.
According to TipRanks.com, Prasad is a 4-star analyst with an average return of 12.0% and a 50.0% success rate. Prasad covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Crispr Therapeutics AG, and Rocket Pharmaceuticals.
Currently, the analyst consensus on Alexion Pharmaceuticals is a Hold with an average price target of $183.60.
See today’s analyst top recommended stocks >>
The company has a one-year high of $187.45 and a one-year low of $99.91. Currently, Alexion Pharmaceuticals has an average volume of 3.96M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on developing life-transforming drugs that are used for treating patients with ultra-rare diseases and disorders.
Read More on ALXN:
Li Auto Lined Up for Further Upside
NVIDIA Improves Language Accuracy With New AI Software
Infosys Public Services Launches Blockchain Network
Fortinet Awarded Partner of the Year by Google Cloud
Aridis Pharmaceuticals (ARDS) Received its Third Buy in a Row
...Read more
ALXN News on the Web
Yahoo Finance
Bullish
NASDAQ.com
Neutral
CNBC
Neutral
MarketWatch
Neutral
Motley Fool
Neutral
Motley Fool
Bullish
Yahoo Finance
Neutral
MTNewswires
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
Not enough data to generate Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is ALXN’s Media Buzz Sentiment?
Currently, no data Available
What is ALXN’s weekly average amount of articles?
Currently, no data Available
What is ALXN’s News Sentiment?
Currently, no data Available